|
Estrogen Receptor Status Of HER2+ Breast Cancer Correlates With Response To Anti-HER
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule...
More... |
| All times are GMT -7. The time now is 11:01 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021